传统的慢性粒细胞白血病(CML)的疗法对病程及患病期长短并无影响。将人天然的或基因重组干扰素(IFN)用作治疗后就会有血液学缓解,同时有部分的或完全的骨髓缓解,表现为骨髓中Ph细胞阴性(细胞核型缓解)。研究对象足自1986年至1988年在多个中心收集的,共322名,均为以往未经治疗或极少治疗的CML Traditional chronic myeloid leukemia (CML) therapy has no effect on the course of the disease and the length of the disease. The use of human natural or recombinant interferon (IFN) as a treatment results in hematological remission with partial or complete bone marrow remission, manifested as a negative Ph cell in the bone marrow (nuclear remission). The objects of the study were collected in multiple centers from 1986 to 1988 with a total of 322 persons, all of which were previously untreated or rarely treated CML.